([2-(Carboxymethyl-{[2-(4-sulfamoyl-phenyl)-ethylcarbamoyl]-methyl}-amino)-ethyl]-{[2-(4-sulfamoyl-phenyl)-ethylcarbamoyl]-methyl}-amino)-acetic acid

InChIKey	`NIYUBSMBQZFXKI-UHFFFAOYSA-N`
Compound Name	([2-(Carboxymethyl-{[2-(4-sulfamoyl-phenyl)-ethylcarbamoyl]-methyl}-amino)-ethyl]-{[2-(4-sulfamoyl-phenyl)-ethylcarbamoyl]-methyl}-amino)-acetic acid
Canonical SMILES	`NS(=O)(=O)c1ccc(CCNC(=O)CN(CCN(CC(=O)O)CC(=O)NCCc2ccc(S(N)(=O)=O)cc2)CC(=O)O)cc1`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	5
Pfam Stratification	Cross-Family
Avg pChEMBL	8.15
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P18505	GABRB1	Homo sapiens	Human	PF02931 PF02932	8.6	pIC50	TTD_MultiTarget
O43570	CA12	Homo sapiens	Human	PF00194	8.6	Ki	ChEMBL;BindingDB
P00918	CA2	Homo sapiens	Human	PF00194	8.1	Ki	ChEMBL;BindingDB
Q16790	CA9	Homo sapiens	Human	PF00194	8.1	Ki	ChEMBL;BindingDB
P00915	CA1	Homo sapiens	Human	PF00194	7.4	Ki	ChEMBL;BindingDB